Effectiveness and Safety of use ior LeukoCIM as prophylaxis and treatment of Neutropenia in patients with HIV / AIDS. |
2009-08-20 |
CIMAB |
Safety assessment of Granulocyte Colony Stimulating Factor:ior LeukoCIM in oncohematologic patients.Phase IV study. |
2009-07-24 |
CIMAB |
Impact of the Granulocytes Colony-Stimulating Factor (ior-LeukoCIM) in primary and secondary prophylaxis and post chemotherapy and/or radiotherapy neutropenia in oncohematological pediatric patients. |
2009-07-24 |
CIMAB |
Effectiveness and Safety of ior EPOCIM in patients with Chronic Renal Failure on dialysis methods. |
2009-07-10 |
CIMAB |
Therapeutic Equivalence between ior EPOCIM and EPO without albumin, for patients with Chronic Renal failure on Peritoneal dialysis methods.(Hemodialysis or peritoneal dialysis). |
2009-07-03 |
CIMAB |
Impact of Human Recombinant Erithoropoietin (ior EPOCIM) in cancer patients with post Chemo and Radiotherapy induced anemia. |
2009-07-03 |
CIMAB |
Impact of Recombinant Human Erythropoietin (ior EPO-CIM) in oncology pediatric patients with post chemo and /or radiotherapy. |
2009-07-03 |
CIMAB |
Amniotic Membrane Transplantation vs Conjunctival–Limbal Autograft for Primary Pterygium |
2009-07-03 |
HHA |
Extract of Mangifera indica L. (Vimang®)-Ischemic Stroke |
2009-03-13 |
CQF |
Evaluation of the neuroprotector effect of an extract of stem bark of Mangifera indica L. (Vimang®) in patient with Spinocerebellar Hereditary Ataxia Type 2 |
2009-03-13 |
CQF |
Effect of the supplementation with Vimang ® on indicators of oxidative stress in young people with Diabetes Mellitus type 1. |
2009-02-27 |
CQF |
Extract of Mangifera indica L. (Vimang®)- Third age- Phase II. |
2009-02-27 |
CQF |
Safety and immunogenicity of commercial Hepatitis B vaccines. |
2009-02-27 |
CIGB |
CITOPROT-III |
2009-02-26 |
CIGB |
Evaluation of the antiinflammatory effect of the Vimang® cream in patients with Dermatitis chronic disease. |
2009-02-12 |
CQF |
Recombinant interferon alpha-2b in paranoid schizophrenia. |
2009-02-11 |
CIGB |
Recombinant IFN alpha-2b for relapsing –remitting multiple sclerosis. |
2009-02-11 |
CIGB |
THERESA |
2008-10-07 |
CIGB |
FarmaPEG-I |
2008-10-07 |
CIGB |
Cutaneous Use of Tisuacryl® |
2008-09-30 |
BIOMAT |